Aegerion Pharmaceuticals, Inc. 4
4 · Aegerion Pharmaceuticals, Inc. · Filed Dec 2, 2015
Insider Transaction Report
Form 4
Louis Roger
See Remarks
Transactions
- Award
Stock Option (right to buy)
2015-12-01+85,000→ 85,000 totalExercise: $10.42Exp: 2025-12-01→ Common Stock (85,000 underlying)
Footnotes (2)
- [F1]The stock option award has an exercise price equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant.
- [F2]25% of the shares of common stock underlying this stock option award will vest on December 1, 2016. The remaining 75% of the shares of common stock underlying this stock option award will vest thereafter in equal monthly installments through December 1, 2019, subject, with limited exceptions, to the Reporting Person's continued employment with the Issuer.